Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human Integrin beta 1/CD29 Biotinylated Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 4 publications
Supplier: R&D Systems BAF1778
This item is not returnable.
View return policy
Description
Integrin beta 1/CD29 Polyclonal specifically detects Integrin beta 1/CD29 in Human samples. It is validated for Western Blot, Flow Cytometry.Specifications
Integrin beta 1/CD29 | |
Polyclonal | |
Biotin | |
P05556 | |
ITGB1 | |
Chinese hamster ovary cell line CHO-derived recombinant human Integrin beta 1 isoform 1A Gln21-Asp728 Accession # P05556 | |
50 μg | |
Primary | |
Detects human Integrin beta 1 in Western blots. In Western blots, approximately 20% cross-reactivity with recombinant mouse (rm) Integrin beta 1 is observed and less than 1% cross-reactivity recombinant human (rh) Integrin beta 2, rhIntegrin beta 3, rmIntegrin beta 6, and rmIntegrin beta 7 is observed. | |
Human | |
IgG |
Western Blot, Flow Cytometry | |
LYOPH | |
Western Blot 0.1 ug/mL, Flow Cytometry 0.25 ug/10^6 cells | |
CD29, CD29 antigen, Fibronectin receptor subunit beta, FNRBVLAB, GPIIA, integrin beta-1, integrin VLA-4 beta subunit, integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includesMDF2, MSK12), ITGB1, MDF2, MSK12, very late activation protein, beta polypeptide, VLA-4 subunit beta, VLA-BETA | |
Goat | |
Affinity Purified | |
RUO | |
3688 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction